Drug Database
ES

estradiol +levonorgestrel (Fem7 Plus / HRT, Merck)

✓ Approved

Merck KGaA · ESR1 · 小分子

什么是 estradiol +levonorgestrel?

estradiol +levonorgestrel 是一种小分子,由Merck KGaA研发。该药已获批,用于治疗相关适应症,给药途径:Topical、Transdermal。

药物档案

商品名Fem7 Plus, HRT, Merck
公司Merck KGaA
药物类别小分子
分子靶点ESR1, PGR
给药途径Topical, Transdermal
状态Approved

作用机制

分子靶点

estradiol +levonorgestrel 作用于 2 个分子靶点:

ESR1estrogen receptor 1 (ER, ESR)
PGRprogesterone receptor (NR3C3, PR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

estradiol +levonorgestrel 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresHormone replacement therapy✓ Approved

相关研究文献

PubMedBiology of sex differences2026-11-19

Mapping the sex-dimorphic hormonal ecosystem in osteoarthritis: non-linear interactions between androgen activity and estrogen.

Deng Bin B, Chen Ting T, Chen Qiao Q, Huang Liangzhi L et al.

The pronounced sex disparity in osteoarthritis (OA) risk implicates sex hormones, yet single-hormone studies have yielded inconsistent results. We hypothesized that androgen activity influences OA not in isolation but within a dynamic network defined by sex, menopausal status, and estradiol. We analyzed 13,848 adults from NHANES (2013-2016, 2021-2023) using an integrated framework combining complex-survey regression, two-way restricted cubic splines, generalized additive models (GAMs), and SHAP-based machine learning to model non-linear interactions across the estradiol-FAI plane. Higher free androgen index (FAI) was significantly associated with lower OA risk only in post-menopausal females (OR = 0.85, 95% CI: 0.74-0.97, P = 0.021); associations in pre-menopausal females (OR = 0.75, P = 0.145) and males (OR = 0.94, P = 0.714) were not statistically significant. Non-linear models revealed distinct regional patterns: a "buffering" pattern in post-menopausal females, where the low-estradiol/low-FAI quadrant exhibited the highest risk (GAM P = 0.002; regional synergy mean = 0.077); a "cross-over" pattern in males (GAM P = 0.042); and a flat surface in pre-menopausal females, serving as a negative control. Candidate boundaries (e.g., estradiol ≈ 2.63, FAI ≈ - 0.54 in post-menopausal females) emerged from SHAP dependence plots as hypothesis-generating indicators requiring formal validation. Machine learning confirmed that standalone predictive contributions of sex hormones were minimal (mean |SHAP| ≤ 0.0135), supporting their role as contextual modulators rather than primary drivers. Sex hormone effects on OA are context-dependent and non-linear, only discernible when examined in combination. The regional risk patterns-particularly the low-low quadrant in post-menopausal females-represent the robust core of our findings and provide a conceptual framework for understanding sex disparities through steroid interaction. Candidate boundaries are hypothesis-generating and await validation.

PMID 43053217
阅读全文 →
PubMedJournal of ovarian research2026-11-19

Effect of estradiol decrease from the hCG trigger day to the embryo transfer day on clinical outcomes in diminished ovarian reserve patients undergoing GnRH-antagonist protocol: a retrospective study.

Yuan Yangxuan Y, Xu Mingyang M, Meng Yicen Y, Ming Lei L et al.

Diminished ovarian reserve (DOR) represents a critical clinical challenge in assisted reproductive technology (ART), and the gonadotropin-releasing hormone (GnRH) antagonist protocol has become a commonly used regimen for DOR treatment. Although estradiol (E₂) is well established as a pivotal regulator of embryo implantation, the prognostic impact of E₂ decrease from the human chorionic gonadotropin (hCG) trigger day to the embryo transfer day on ART outcomes remains unclear in DOR patients undergoing a GnRH-antagonist protocol. This retrospective study included 570 eligible in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles of DOR patients classified as POSEIDON Groups 3 and 4, who received the GnRH-antagonist protocol at Renmin Hospital of Wuhan University between July 2019 and September 2024. The optimal cut-off value for E₂ decrease was determined using receiver operating characteristic (ROC) curve analysis. Cycles were stratified into two groups based on the cut-off: Group A (E₂ decrease < 51%) and Group B (E₂ decrease ≥ 51%). Reproductive outcomes were compared between the two groups, and multivariable binary logistic regression analysis was performed to evaluate factors associated with clinical pregnancy. Compared with the patients in non-pregnant group, the pregnant group had lower maternal age, P levels on the hCG trigger day and duration of antagonist, but had higher BMI, AFC and the proportion of patients with E₂ decrease < 51%. The logistic regression analysis indicated that the E₂ decrease group was independently associated with clinical pregnancy after multivariable adjustment. Based on the ROC-derived cut-off value, Group A had significantly higher clinical pregnancy rates [47.4% (54/114) versus 26.8% (33/123) (P < 0.01)] and embryo implantation rates [33.0% (60/182) versus 20.0% (39/195) (P < 0.01)] compared with Group B. DOR patients with an E₂ decrease of less than 51% from the hCG trigger day to the embryo transfer day showed relatively better clinical outcomes under a GnRH-antagonist protocol. Monitoring peri-transfer E₂ changes may provide complementary prognostic information.

PMID 43053039
阅读全文 →
PubMedBMC infectious diseases2026-11-19

CT-detected gynecomastia in men living with HIV: prevalence, radiological patterns, and associated factors.

Akca Veysel V, Sarı Ferda Bacaksızlar FB, Togan Turhan T

To determine the prevalence of CT-detected gynecomastia in men living with HIV, characterize its radiological subtypes, and investigate potential associations with hormonal, clinical, virological, and treatment-related factors. This retrospective observational study included 170 adult men living with HIV who underwent thoracic computed tomography (CT) examinations performed on a Somatom Definition Flash multidetector CT scanner (Siemens Healthineers, Forchheim, Germany) between January 2023 and January 2025. CT examinations were reviewed for the presence of gynecomastia, laterality, and radiological subtype (nodular, dendritic, or diffuse). Demographic characteristics, duration of HIV infection, antiretroviral treatment (ART) regimens, hormonal parameters, body mass index (BMI), CD4 and CD8 counts, CD4/CD8 ratio, HIV RNA levels, and CDC stage were obtained from medical records. Multivariable logistic regression analyses were performed to identify factors associated with gynecomastia and its radiological subtypes. The mean age of the study population was 39.7 ± 11.8 years. Gynecomastia was identified in 60 patients (35.3%), with bilateral involvement in 86.7% of cases. Bilateral disease was present in 68.2% of nodular, 84.2% of dendritic, and 95.2% of diffuse gynecomastia cases. The prevalence of gynecomastia did not differ significantly among ART regimens (p = 0.743). Estradiol levels, testosterone levels, estradiol-to-testosterone ratio, BMI, CD4 count, CD8 count, CD4/CD8 ratio, and HIV RNA levels were not independently associated with gynecomastia. In multivariable analyses, use of DTG/3TC was associated with lower odds of gynecomastia (OR: 0.115, p = 0.033). For diffuse gynecomastia, longer duration of HIV infection was independently associated with increased odds (OR: 1.419, p = 0.005). No independent predictors were identified for nodular or dendritic gynecomastia. Gynecomastia is a common incidental finding on thoracic CT in men living with HIV, affecting more than one-third of patients in this cohort. Despite the relatively young age of the study population, the prevalence was comparable to that reported in large CT-based studies from the general Turkish population. HIV duration, rather than hormonal, immunological, or virological parameters, was associated with diffuse gynecomastia, suggesting that breast tissue changes may reflect cumulative long-term effects of HIV infection and its treatment. Not applicable.

PMID 43052786
阅读全文 →
PubMedBMC veterinary research2026-11-19

The interactive regulatory effects of light exposure and bamboo fiber supplementation on growth performance, hormone levels, and gut microbiome composition in white-feathered broiler breeder chickens.

Wang Zhiyao Z, Qiu Huiling H, Qiao Changming C, Song Shujun S et al.

This study investigated the interactive effects of light intensity (4 Lux vs. 5 Lux) and bamboo fiber supplementation (0% vs. 1%) on growth performance, reproductive hormones, antioxidant status, laying performance, egg quality, and intestinal flora in Arbor Acres broiler breeders. A total of 32,000 Arbor Acres white broiler breeder hens at 49 days of age were randomly assigned to four treatment groups: 4 Lux basal diet, 5 Lux basal diet, 4 Lux + 1% bamboo fiber, and 5 Lux + 1% bamboo fiber, with eight replicates per group and 1,000 hens per replicate. The experimental period was 126 days. Two-way ANOVA showed significant light × fiber interactions for estradiol, GSH-Px, MDA, and eggshell lightness L (P < 0.05). Light intensity alone affected FSH, UA, and eggshell color a* (P < 0.05). One-way ANOVA with post-hoc comparisons further showed that the 5 Lux + bamboo fiber group achieved the highest laying rate (45.40%) and significantly increased MT levels (54.61%). Compared to the 4 Lux group, the 5 Lux group showed increased FSH, E2, and GSH-Px activity, but decreased eggshell thickness (P < 0.05). Relative to the 5 Lux group, the 5 Lux + bamboo fiber group exhibited increased GSH, MDA, and GSH-Px, but decreased E2, ALB, and γ-GT (P < 0.05). This group also significantly reshaped the intestinal flora structure, increasing the Firmicutes/Bacteroidetes ratio from 1.91 to 19.34 and enriching beneficial bacteria such as Lactobacillus and Limosilactobacillus. Combined 5 Lux lighting and 1% bamboo fiber improved laying rate and antioxidant status. These results suggest that light intensity and fiber intake can be managed together to support breeder performance.

PMID 43053087
阅读全文 →
PubMedJournal of molecular histology2026-11-18

Efficacy of sacubitril/valsartan and bosentan in amelioration of estradiol induced endometrial changes via regulation of Wnt/β-catenin and IL6/JAK/STAT3 pathways.

Refaie Marwa Monier Mahmoud MMM, Ibrahim Manar Fouli Gaber MFG, Sherkawy Hoda S HS, Mohamed Hala Mansour Mohamed HMM et al.

Endometrial hyperplasia (EHP) commonly affects elderly females in the pre-menopausal period and can progress to carcinoma. Immune dysregulation has a crucial role in mediating such disorders. Thus, studying its pathogenesis and finding ameliorative medical treatment becomes mandatory. This motivated us to perform the current experiment of induced EHP in female rats using estradiol (EST) (2 mg/kg/day) intramuscular injection with or without using bosentan (BOS) (50 mg/kg/day) and/or Sacubitril/valsartan (SV) (60 mg/kg/day) for 3 weeks. We found typical histopathological features of EHP, elevation of total oxidant status (TOS), oxidative stress index (OSI), interleukin 6/Janus kinase/Signal transducer and activator of transcription 3 (IL6/JAK/STAT3), and Wnt/β-catenin pathways with increased uterine weights. However, there is a significant diminution in total antioxidant capacity (TAC) and caspase-3 immune expression. Interestingly, BOS and/or SV administration significantly ameliorated the histopathological and biochemical disturbances. This improvement may be attributed to the pharmacological ability of SV to block angiotensin receptors and neprilysin besides blocking endothelin receptors by BOS. Furthermore, SV/BOS could regulate apoptosis with antioxidant and anti-inflammatory properties.

PMID 43049843
阅读全文 →
PubMedContact dermatitis2026-11-18

First Cases of Allergic Contact Dermatitis From the New FreeStyle Libre 3 Sensor: Small Device, Multiple Allergens.

Kanokrungsee Silada S, Dendooven Ella E, Foubert Kenn K, Naessens Tania T et al.

Allergic contact dermatitis (ACD) from glucose sensors has become increasingly common. Newer devices, such as FreeStyle Libre 3 (Abbott Diabetes Care, UK), have been developed to enhance performance and reduce skin reactions. No ACD cases linked to this particular device have been reported to date. To document the first cases of ACD linked to the FreeStyle Libre 3 sensor and to identify potential culprit allergenic components through patch testing and chemical analyses. A retrospective chart review was conducted on 15 patients with suspected ACD related to the FreeStyle Libre 3 device who underwent patch testing at Antwerp University Hospital between November 2023 and November 2025. Chemical analyses of the device and associated adhesive components were performed using gas chromatography-mass spectrometry (GC-MS). Ten patients (67%) were diagnosed with ACD and most had prior exposure to other glucose sensors. The most frequent allergens were colophonium and related compounds, followed by (meth)acrylates, isocyanates and tert-butylphenol (TBP) derivatives. GC-MS analyses revealed the presence of most of these chemicals. Multiple newly identified as well as (modified) classic sensitizers contribute to ACD from the FreeStyle Libre 3 glucose sensor. Comprehensive ingredient disclosure and extended patch testing are essential for accurate diagnosis and prevention.

PMID 43046828
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多estradiol +levonorgestrel